Introduction {#sec1-1}
============

The deficiency of vitamin D or hypovitaminosis D has emerged as an important area of research. Inadequate levels of vitamin D are widespread irrespective of age, gender, race, and geography[@ref1]. Vitamin D a fat soluble vitamin also functions as a hormone. It is involved in maintaining the integrity of skeletal system as it regulates parathyroid hormone, calcium and phosphorous metabolism[@ref2]. It is also essential for calcium homoeostasis and musculoskeletal health[@ref3][@ref4]. The level of 25-hydroxyvitamin D \[25(OH)D\] is considered as the most reliable index for assessing an individual\'s vitamin D status[@ref4][@ref5].

Skeletal consequences of hypovitaminosis D {#sec1-2}
==========================================

Deficiency of vitamin D and calcium may lead to osteoporosis. Deficiency of vitamin D can cause low bone mass (rickets in children and osteomalacia in adults) and muscle weakness, thus increasing the risk of fracture[@ref6][@ref7]. The intestinal calcium absorption reduces to as low as 10-15 per cent in vitamin D-deficient state, whereas it is 30-80 per cent in vitamin D-sufficient state[@ref8]. Adequate intake of calcium together with vitamin D can help in maintaining peak bone mass[@ref7]. Adequate levels of vitamin D during adolescence can be helpful in reducing the risk of osteoporosis during adulthood[@ref7].

Extra-skeletal consequences of hypovitaminosis D {#sec1-3}
================================================

The presence of vitamin D receptors and enzymes which produce the active form of vitamin D (*i.e*. 1,25-dihydroxyvitamin D) in the skin have highlighted the potential role of vitamin D in reducing risk of chronic diseases, such as carcinomas, autoimmune diseases, infectious diseases and cardiovascular diseases[@ref2]. However, the Institute of Medicine Committee in its report on dietary requirements for calcium and vitamin D has concluded that there are inconclusive and inconsistent data that vitamin D and calcium lower the risk of cancer, cardiovascular disease, diabetes, infections, autoimmune disorders and other extra-skeletal consequences[@ref9].

Vitamin D deficiency is prevalent in India. Factors such as length and timing of sun exposure, amount of skin exposed, latitude, season, level of pollution in atmosphere, clothing, skin pigmentation, application of sunscreen, dietary factors and genetic factors may lead to hypovitaminosis D[@ref4][@ref7][@ref8][@ref10]. Other factors which may cause lower levels of vitamin D include changing food habits, consuming only vegetarian food, less intake of vitamin D-fortified foods, high fibre diet-containing phosphates and phytates, cultural and traditional practices such as '*burqa*' and '*pardah* system', and repeated, unplanned and unspaced pregnancies[@ref4][@ref7][@ref11]. Association between modifiable factors such as sun exposure, sunscreen use, geographic allocation (latitude and altitude), atmospheric pollution, clothing, melanin pigmentation, ageing and vegetarian diet and decreased vitamin D synthesis has been reported[@ref12][@ref13].

The primary source of vitamin D is sunlight. Vitamin D is synthesized in the skin by conversion of 7-dehydrocholesterol to cholecalciferol (vitamin D~3~) when it is exposed to ultraviolet B radiation (wavelength: 290-320 nm)[@ref4][@ref14]. Dietary sources of vitamin D include animal products such as fatty fish, food items fortified with vitamin D and supplements[@ref9][@ref14]. Adequate levels of vitamin D can be achieved by exposure to sunlight[@ref1]. Exposing skin (arms and face area) to sunlight without applying sunscreen for half an hour (between 1000 and 1400 h) every day is considered adequate to avoid hypovitaminosis D[@ref7]. However, even in tropical countries like India which get plenty of sunshine, a high prevalence of hypovitaminosis D (70-100%) has been observed among healthy individuals due to socio-economic and cultural constraints[@ref1].

An individual\'s serum concentration of 25(OH)D of at least 20 ng/ml (50 nmol/l) is considered sufficient, levels \>30 ng/ml (75 nmol/l) are not related with benefits, and levels \>50 ng/ml (125 nmol/l) have been associated with some risks[@ref9]. Distinct cut-offs have been used to define hypovitaminosis D and the level of severity of its deficiency by different experts in their studies. [Table I](#T1){ref-type="table"} lists some of the diagnostic cut-offs.

###### 

Some diagnostic cut-offs for serum 25-hydroxyvitamin D \[25(OH)D\] concentrations for the detection of hypovitaminosis D

  Reference                                                                                                    Diagnostic cut-offs for serum 25(OH)D concentrations (ng/ml)
  ------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------
  Lips, 2001[@ref15]                                                                                           10-20: Mild hypovitaminosis D
  5-10: Moderate hypovitaminosis D                                                                             
  \<5: Severe hypovitaminosis D                                                                                
  Consensus by Dawson-Hughes *et al*, 2005[@ref16]; Grant and Hollick, 2005[@ref17] and Hollis, 2005[@ref18]   \<20: Vitamin D deficient
  20-30: Vitamin D insufficient                                                                                
  \>30: Vitamin D sufficient                                                                                   

Prevalence of hypovitaminosis D among different age groups in India {#sec1-4}
===================================================================

Vitamin D deficiency has been observed in countries which are 'sunshine deficient' and 'sunshine sufficient'[@ref14]. It is considered as a public health problem in India. Even though Indians receive abundant sunshine throughout the year, hypovitaminosis D is still considered as a growing problem[@ref19][@ref20]. A high prevalence (50-90%) of vitamin D deficiency along with low dietary calcium intake has been documented in Indian population[@ref3].

A review of literature was carried out to identify studies conducted to assess the prevalence of vitamin D deficiency in India among different age groups. Selected studies (since 2005) on the prevalence of vitamin D deficiency have been tabulated for different age groups such as school-going children; infants, pregnant and lactating mothers and adults in this review article. Selected randomized controlled trials on vitamin D conducted in India have also been tabulated. Studies reviewed have been divided into the following:

 {#sec2-1}

### Prevalence studies {#sec3-1}

Several studies conducted to assess hypovitaminosis D in different age groups in India reveal a widespread prevalence of vitamin D deficiency among all age groups, such as school-aged children, pregnant and lactating mothers, their neonates and adults ([Table II](#T2){ref-type="table"}). It should be noted that based on selected studies included in [Table II](#T2){ref-type="table"}, the prevalence of hypovitaminosis D ranged from 84.9 to 100 per cent among school-going children, 42 to 74 per cent among pregnant women, 44.3 to 66.7 per cent among infants, 70 to 81.1 per cent among lactating mothers and 30 to 91.2 per cent among adults. Hypovitaminosis D was present in all obese children aged 6-17 yr[@ref22]; in 93 per cent children aged 6-18 yr[@ref21] and in 93 and 85 per cent children (aged 10-18 yr) belonging to lower and upper socio-economic groups, respectively[@ref23]. A high prevalence of vitamin D deficiency (\>65%) was reported among infants, pregnant and lactating mothers[@ref24][@ref25][@ref26]. One study reported 42 per cent prevalence of vitamin D deficiency among pregnant women[@ref12]. It is important that pregnant women have adequate levels of vitamin D as undernutrition in pregnant women has been linked with birth of low birth weight babies[@ref34]. Similarly, a high prevalence of vitamin D deficiency has been reported among adults[@ref27][@ref28][@ref29][@ref30][@ref31][@ref32][@ref33]. All studies included in this Table used radioimmunoassay and only two studies[@ref21][@ref33] used chemiluminescence to measure serum 25(OH)D levels. A high prevalence of deficiency of vitamin D among healthy Indian population, irrespective of age, gender, menopausal status and urban/rural areas, was also reported in a systematic review[@ref35].

###### 

Selected studies on the prevalence of hypovitaminosis D among different age and physiological groups in India

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                                                                                 Locale                                            Age group                                       Sample size                                                                                               Criteria for defining hypovitaminosis D based on serum 25(OH)D levels (ng/ml or nmol/l)   Method of analysis   Prevalence of hypovitaminosis D (%)
  ----------------------------------------------------------------------------------------- ------------------------------------------------- ----------------------------------------------- --------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- -------------------- -------------------------------------------------------------------------
  School going children                                                                                                                                                                                                                                                                                                                                                                                                

  Kapil *et al*, 2017[@ref21]                                                               Shimla, Himachal Pradesh                          6-18 yr                                         626                                                                                                       Sufficient: ≥30 ng/ml                                                                     Chemiluminescence    Sufficient: 1.1

  Insufficient: 5.9                                                                                                                                                                                                                                                                                                                                                                                                    

  Deficient: 93                                                                                                                                                                                                                                                                                                                                                                                                        

  Insufficient: 20-29 ng/ml                                                                                                                                                                                                                                                                                                                                                                                            

  Deficient: \<20 ng/ml                                                                                                                                                                                                                                                                                                                                                                                                

  Khadgawat *et al*, 2012[@ref22]                                                           New Delhi (hospital- based)                       6-17 yr (obese adolescents)                     62                                                                                                        \<20 ng/ml                                                                                Radioimmunoassay     100

  \<5 ng/ml: 17.7                                                                                                                                                                                                                                                                                                                                                                                                      

  5-\<10 ng/ml: 48.3                                                                                                                                                                                                                                                                                                                                                                                                   

  ≥10-\<20 ng/ml: 33.8                                                                                                                                                                                                                                                                                                                                                                                                 

  Marwaha *et al*, 2005[@ref23]                                                             New Delhi                                         10-18 yr                                        5137                                                                                                      \<20 ng/ml                                                                                Radioimmunoassay     LSES: 92.6

  USES: 84.9                                                                                                                                                                                                                                                                                                                                                                                                           

  LSES: 3089 (1079 boys, 2010 girls)\                                                                                                                                                                                                                                                                                                                                                                                  
  USES: 2048 (968 boys, 1080 girls)                                                                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                       

  Infants, pregnant and lactating mothers                                                                                                                                                                                                                                                                                                                                                                              

  Sahu *et al*, 2009[@ref24]                                                                Lucknow                                           Adolescent girls: 10-20 yr                      121 adolescent girls; 139 pregnant women in the second trimester                                          \<50 nmol/l                                                                               Radioimmunoassay     Adolescent girls: 88·6

  Pregnant women: 74                                                                                                                                                                                                                                                                                                                                                                                                   

  Pregnant women: Not mentioned                                                                                                                                                                                                                                                                                                                                                                                        

  Agarwal *et al*, 2010[@ref25]                                                             Delhi                                             Exclusively breastfed infant- mother pairs      179 infant-mother pairs (96 AGA (Group 1) and 83 SGA infants (Group 2) recruited at 10 wk)                \<11 ng/ml                                                                                Radioimmunoassay     Infants at 10 wk: 55.67 (total), 55.77 (AGA), 55.26 (SGA)

  Infants at 6 months: 44.33 (total), 38.46 (AGA), 57.11 (SGA)                                                                                                                                                                                                                                                                                                                                                         

  At 6 months: 52 (Group 1) and 45 (Group 2) evaluated                                      Mothers: 70                                                                                                                                                                                                                                                                                                                

  Jain *et al*, 2011[@ref26]                                                                New Delhi                                         Infants aged 2.5-3.5 months and their mothers   98 infants and their mothers \[47 enrolled in winter (November-January) and 51 in summer (April-June)\]   Deficiency: ≤15 ng/ml                                                                     Radioimmunoassay     Deficiency: Infants: 66.7; mothers: 81.1

  Insufficiency: Infants: 19.8; mothers: 11.6                                                                                                                                                                                                                                                                                                                                                                          

  Insufficiency: 15-20 ng/ml, severe deficiency: \<5 ng/ml                                  Severe deficiency: Infants: 27.1; mothers: 23.2                                                                                                                                                                                                                                                                            

  Dasgupta *et al*, 2012[@ref12]                                                            North-Eastern India                               20-40 yr                                        50 pregnant females studied during first trimester of pregnancy                                           Not mentioned                                                                             Radioimmunoassay     Cases: 42% had vitamin D deficiency and 14% had vitamin D insufficiency

  Controls: 20% had vitamin D deficiency and 24% had vitamin D insufficiency (*P*=0.0375)                                                                                                                                                                                                                                                                                                                              

  50 age- and BMI-matched females taken as controls                                                                                                                                                                                                                                                                                                                                                                    

  Adults                                                                                                                                                                                                                                                                                                                                                                                                               

  Harinarayan 2005[@ref27]                                                                  Tirupati                                          \-                                              164 post-menopausal women                                                                                 Deficiency: \<10 ng/ml                                                                    Radioimmunoassay     Deficiency: 30

  Insufficiency: 52                                                                                                                                                                                                                                                                                                                                                                                                    

  Normal: 18                                                                                                                                                                                                                                                                                                                                                                                                           

  Insufficiency: 10-20 ng/ml                                                                                                                                                                                                                                                                                                                                                                                           

  Normal: \>20 ng/ml                                                                                                                                                                                                                                                                                                                                                                                                   

  Harinarayan *et al*, 2007[@ref28]                                                         Tirupati                                          \-                                              943 (urban)                                                                                               Deficiency: \<20 ng/ml                                                                    Radioimmunoassay     Deficiency: Rural - men: 44; women: 70

  205 (rural)                                                                               Insufficiency: 20-30 ng/ml                        Urban - men: 62; women: 75                                                                                                                                                                                                                                               

  Sufficiency: Rural - men: 39.5; women: 29                                                                                                                                                                                                                                                                                                                                                                            

  Sufficiency: \>30 ng/ml                                                                                                                                                                                                                                                                                                                                                                                              

  Urban - men: 26; women: 19                                                                                                                                                                                                                                                                                                                                                                                           

  Insufficiency: Rural - men: 16.5; women: 1                                                                                                                                                                                                                                                                                                                                                                           

  Urban - men: 12; women: 6                                                                                                                                                                                                                                                                                                                                                                                            

  Zargar *et al*, 2007[@ref29]                                                              Kashmir                                           18-40 yr                                        92 (64 men; 28 NPNL women)                                                                                Deficiency:                                                                               Radioimmunoassay     Deficiency: 83

  Mild deficiency: 25                                                                                                                                                                                                                                                                                                                                                                                                  

  Moderate deficiency: 33                                                                                                                                                                                                                                                                                                                                                                                              

  \<50 nmol/l                                                                               Severe deficiency: 25                                                                                                                                                                                                                                                                                                      

  Mild: 25-50 nmol/l, Moderate: 12.5-25 nmol/l                                                                                                                                                                                                                                                                                                                                                                         

  Severe: \<12.5 nmol/l                                                                                                                                                                                                                                                                                                                                                                                                

  Goswami *et al*, 2009[@ref30]                                                             Delhi                                             16-60 yr                                        642 (244 males;                                                                                           ≤25.0 nmol/l                                                                              Radioimmunoassay     87

  398 females)                                                                                                                                                                                                                                                                                                                                                                                                         

  Shivane *et al*, 2011[@ref31]                                                             Mumbai                                            25-35 yr                                        1137                                                                                                      Severe deficiency: \<5 ng/ml                                                              Radioimmunoassay     Severe deficiency: 2.9

  Moderate deficiency: 5-10 ng/ml                                                           Moderate deficiency: 16.45                                                                                                                                                                                                                                                                                                 

  Mild deficiency: 10-20 ng/ml                                                              Mild deficiency: 51.45                                                                                                                                                                                                                                                                                                     

  Sufficiency: \>20 ng/ml                                                                   Sufficiency: 30.78                                                                                                                                                                                                                                                                                                         

  Optimal status: \>30 ng/ml                                                                Optimal status: 7.2                                                                                                                                                                                                                                                                                                        

  Marwaha *et al*, 2011[@ref32]                                                             Delhi                                             ≥50 yr                                          1600 adults                                                                                               \<20 ng/ml                                                                                Radioimmunoassay     Deficiency: 91.2

  Goswami *et al*, 2015[@ref33]                                                             New Delhi                                         \-                                              194 male adults further categorized into: Outdoor (n=88) Mixed outdoor-indoor (n=32)                      Deficient: ≤20.0 ng/ml                                                                    Chemiluminescence    Deficient: 14.8 (outdoors), 62.5 (mixed), 97.3 (indoors)

  Insufficient: 45.4 (outdoors), 34.4 (mixed), 2.7 (indoors)                                                                                                                                                                                                                                                                                                                                                           

  Insufficient: 20.1-30 ng/ml                                                                                                                                                                                                                                                                                                                                                                                          

  Sufficient: 39.8 (outdoors), 3.1 (mixed), 0 (indoors)                                                                                                                                                                                                                                                                                                                                                                

  Sufficient: \>30.0 ng/ml                                                                                                                                                                                                                                                                                                                                                                                             

  Indoor (n=74)                                                                                                                                                                                                                                                                                                                                                                                                        
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

LSES, lower socio-economic schools; USES, upper socioeconomic schools; BMI, body mass index; AGA, appropriate-for-gestational age; SGA, small-for-gestational age; NPNL, non-pregnant non-lactating

### Randomized controlled trials {#sec3-2}

Selected randomized controlled trials on vitamin D supplementation conducted in India have been listed in [Table III](#T3){ref-type="table"}. In most of these studies, cholecalciferol was given as a supplement. Calcium supplementation was also provided along with vitamin D supplementation. The duration of intervention ranged from three months to one year. Some studies mentioned the percentage of vitamin D-deficient individuals, whereas some only presented the mean/median values of 25(OH)D levels before and after the intervention.

###### 

Selected randomized controlled trials on vitamin D in India

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                                                              Locale                             Age group                           Sample size                                                              Dose and duration                                                                                                                                                                                                                                                                                          Criteria for defining hypovitaminosis D based on serum 25(OH)D levels (ng/ml or nmol/l)   Results
  ---------------------------------------------------------------------- ---------------------------------- ----------------------------------- ------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------
  Harinarayan *et al*, 2015[@ref36]                                      \-                                 \-                                  132 (n=41, 35 and 56 each at baseline and 8 wk; n=41, 23, 30 at 20 wk)   Protocol 1 (intensive regimen): 60,000 IU oral cholecalciferol once/week for 2 months+ elemental calcium (1 g/day)+ supervised monitoring Protocol 2 (parenteral regimen): single dose cholecalciferol 600,000 IU+elemental calcium 1 g/day.\                                                              Sufficiency: \>30 ng/ml                                                                   Baseline
                                                                                                                                                                                                                         Oral cholecalciferol 600,000 IU/fortnight+elemental calcium 1 g/day for 3 months\                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                         Protocol 3: Similar to Protocol 1+No supervised monitoring                                                                                                                                                                                                                                                                                                                                           

  Deficiency: 98% (Protocol 1), 100% (Protocol 2), 96.5% (Protocol 3)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  8 wk 17% (Protocol 1), 6% (Protocol 2), 46% (Protocol 3)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  20 wk 24% (Protocol 1), 0% (Protocol 2), 23% (Protocol 3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Deficiency: \<20 ng/ml                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Goswami *et al*, 2012[@ref37]                                          Delhi                              ≥21 yr (females)                    153                                                                      4 groups: double placebo (n=37), calcium/placebo (n=38), cholecalciferol/placebo (n=39) and cholecalciferol/calcium (n=39)\                                                                                                                                                                                Not mentioned                                                                             An increase of 20.6±8.73 and 17.5±8.61 was seen in serum 25(OH)\
                                                                                                                                                                                                                         Cholecalciferol: 60,000 IU/wk for 8 wk followed by 60,000 IU/fortnight\                                                                                                                                                                                                                                                                                                                              D (ng/ml) levels in cholecalciferol/placebo and cholecalciferol/calcium group, respectively
                                                                                                                                                                                                                         Elemental calcium: 500 mg twice/day for 6 months                                                                                                                                                                                                                                                                                                                                                     

  Khadgawat *et al*, 2013[@ref38]                                        National Capital Region of Delhi   10-14 yr                            n=713 (boys-300; girls-413)                                              All groups received 200 ml milk/ day Group A (n=237): unfortified milk Group B (n=243): milk fortified with 600 IU (15 µg) of vitamin D Group C (n=233): milk fortified with 1000 IU (25 µg) of vitamin D for 12 wk                                                                                        \<20 ng/ml                                                                                Baseline serum 25(OH)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              D level (ng/ml)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Group A: 11.74±5.23\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Group B: 11.42±5.24\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Group C: 11.94±5.62\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Endline serum 25 (OH)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              D level (ng/ml)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Group A: 10.83±5.24\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Group B: 22.87±6.75 (*P*\<0.001)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Group C: 27.67±8.47 (*P*\<0.001)

  Garg *et al*, 2013[@ref39]^\*^                                         New Delhi                          10-15 yr                            482                                                                      Group 1 (n=238), Group 2 (n=139) and Group 3 (n=134) each given 60,000 IU of vitamin D~3~ granules (cholecalciferol)/wk along with unfortified milk (200 ml) daily for 4, 6 and 8 wk, respectively Groups 2 and 3 received fortified milk (200 ml) (fortified with 600 IU of vitamin D3) daily for 12 wk   Sufficiency: \>75 nmol/l (\>30 ng/ml) Deficiency: \<50 nmol/l (\<20 ng/ml)                In all 3 groups, \>90% subjects attained vitamin D sufficiency

  Agarwal *et al*, 2013[@ref13]^\^^                                      New Delhi                          40-73 yr (Post- menopausal women)   64                                                                       Group A (control): 1000 mg calcium carbonate (n=21)\                                                                                                                                                                                                                                                       Deficiency: \<20 ng/ml (50 nmol/l)\                                                       Baseline: 83.7% (deficiency), 8.7% (insufficiency) and 7.6% (normal)\
                                                                                                                                                                                                                         Group B: 1000 mg calcium carbonate+500 IU vitamin D (n=25)\                                                                                                                                                                                                                                                Insufficiency: 20-30 ng/ml (525-725 nmol/l)\                                              Post-intervention: Normal: 0 (Group A), 4% (Group B), 22% (Group C)\
                                                                                                                                                                                                                         Group C: 1000 mg calcium carbonate+1000 IU vitamin D (n=18) for 3 months                                                                                                                                                                                                                                   Normal:\>30 ng/ml                                                                         Sufficiency: Group A (4.7%), 12 % (Group B), 38.9% (Group C)

  Marwaha *et al*, 2010[@ref40]                                          Delhi                              6-17 yr                             290 healthy schoolgirls (LSES-124; USES-166)                             Cholecalciferol granules (sachets) 60,000 IU of cholecalciferol granules given as follows\                                                                                                                                                                                                                 Not mentioned                                                                             Serum 25(OH)D (nmol/l) LSES\
                                                                                                                                                                                                                         Two-monthly D~3~ Group: 1000 IU/day every 2 months\                                                                                                                                                                                                                                                                                                                                                  Two-monthly D~3~ group (n=60)\
                                                                                                                                                                                                                         One-monthly D~3~ group: 2000 IU/day every month for one year                                                                                                                                                                                                                                                                                                                                         Baseline: 31.20 (1.68)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              6 months: 39.53 (2.01)^\*^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              12 months: 53.0 (3.05)^\#,\$^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              One-monthly D~3~ group (n=64)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Baseline: 32.93 (1.37)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              6 months: 43.90 (1.50)^\*^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              12 months: 59.33 (2.64)^\#,\$^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              USES Two-monthly D~3~ group (n=81) Baseline: 29.13 (1.54)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              6 months: 39.55 (1.24)^\*^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              12 months: 38.25 (2.13)^\#^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              One-monthly D3 group (n=85)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Baseline: 30.80 (1.39)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              6 months: 46.81 (1.45)^\*^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              12 months: 49.94 (2.01)^\#^

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ^\*^*P*\<0.05 for baseline vs 6 months\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ^\#^*P*\<0.05 for baseline vs 12 months\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ^\$^*P*\<0.05 for 6 months vs 12 months
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Open label non-randomized prospective trial; ^\^^Open label study; LSES, lower socio-economic strata;

USES, upper socio-economic strata

### Way forward: Management of hypovitaminosis D {#sec3-3}

In India, fortifying staple foods with vitamin D can be a feasible population-based strategy[@ref1]. It is vital that calcium supplementation should also be provided along vitamin D supplementation[@ref41]. Evidence suggests that fortification of milk with vitamin D is an efficient and safe way of improving serum 25(OH)D levels in India[@ref38]. It is also suggested that supplementary nutrition programmes launched by the government should include local food items fortified with micronutrients including vitamin D to address this issue. Stakeholders from food industry can also help in making fortification programmes successful in India[@ref1]. Creating awareness among physicians and the general population will also help in combating the problem to some extent.

Conclusion {#sec1-5}
==========

Hypovitaminosis D is prevalent among Indian population, irrespective of age, physiological status and geographical location. In India, fortifying staple foods with vitamin D, supplementing vitamin D along with calcium and inclusion of local food items fortified with vitamin D in supplementary nutrition programmes launched by the government may help in improving the problem of hypovitaminosis D.
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